Dr. Bipin Gupta, PhD | Founder, CEO & CSO
Dr. Gupta founded DBS in 1994. He completed his post-doctoral studies at Stanford Medical School and worked as a scientist in the field of IHC. Dr. Gupta has numerous publications in the area of IHC.
Gerald Weiss M.D.,F.C.A.P | Consulting Pathologist
Dr. Weiss is a Board Certified Pathologist (Anatomic and Clinical Pathology) with a special interest in immunohistochemistry. He has founded and directed a number of CLIA Laboratories. He is currently Director of Laboratories at Regional Medical Center of San Jose and Bioreference Laboratories in Campbell California. He serves on the Board of Directors of the California Society of Pathologists.
Marc Key, PhD | Chief Scientific Advisor
Marc Key, has over 25 years of experience in research and product development. Dr. Key has held senior positions with companies such as Dako and BioGenex Corporation. He has been responsible for R & D teams launching hundreds of products into the pathology market and holds some of the most significant patents in the field of Immunohistochemistry testing. Dr. Key holds a BS from Iowa State University, an MS from the University of Montana and a PhD from the Medical University of South Carolina.
Saul Ship, PhD | VP International Business Development
Saul Ship, has over 25 years of marketing and management experience in the diagnostics industry. He has helped many diagnostics and biotech companies develop and market their products internationally. Dr. Ship is responsible for developing and managing Diagnostic BioSystems global distributor network outside the United States.